Interactive Brokers shares jump as it secures spot in S&P 500
Cathie Wood’s ARK ETFs have published their daily trades for Wednesday, April 2nd, 2025, with a mix of buys and sells that continue to shape their innovative investment strategies. The most significant dollar-value trade of the day saw ARK’s ARKK ETF acquiring 6875 shares of Robinhood Markets Inc (NASDAQ:HOOD) for a total value of approximately $289,849. This purchase suggests a growing confidence in the online brokerage platform, following a similar but larger acquisition of HOOD shares the previous week.
In another notable transaction, ARK bolstered its position in GitLab Inc (NASDAQ:GTLB), buying 2075 shares through ARKK and 614 shares through ARKW, amounting to a total investment of $128,130. This move extends a trend of consistent accumulation of GTLB stock, as seen in the substantial purchases made in the prior days, indicating a strategic emphasis on the software development platform.
On the sell side, ARK divested from two biotech companies. The ARKK ETF sold 19903 shares of Prime Medicine Inc (NASDAQ:PRME) for $35,526, and the ARKG ETF offloaded 73541 shares of Repare Therapeutics Inc (NASDAQ:RPTX) totaling $75,011. These sales contribute to a pattern of reducing exposure in the biotech sector, as evidenced by the sales of PRME and RPTX shares in recent days.
Investors following ARK’s trading activity may find these transactions insightful, as they reflect the fund’s ongoing adjustments to its investment thesis. While the focus on GitLab and Robinhood suggests a bullish stance on technology and fintech, the sales in biotech hint at a more cautious approach to this volatile sector.
As the market continues to evolve, Cathie Wood’s ARK ETFs remain a closely watched barometer for innovation-focused investing, with their daily trades offering a transparent look into the decisions driving their performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.